Tests treatment safety and results for Chronic Musculoskeletal Pain
Official title Effectiveness of Communication-Focused Pain Neuroscience Education in Chronic Musculoskeletal Pain
ClinicalTrials.gov ID: NCT07001449
What this study is testing
- What it's testing
- This randomized controlled trial aims to evaluate the effectiveness of the "Algo(S)Therapy" Pain Neuroscience Education (PNE) program in patients with chronic musculoskeletal pain. The study will assess whether the integration of communication skills training for physiotherapists enhances the outcomes of PNE.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Adults aged 18 to 65 years
- Diagnosis of chronic musculoskeletal pain in the lumbar spine, cervical spine, shoulder, or knee
- Pain duration longer than 3 months
- Pain intensity ≥3/10 on the Numeric Pain Rating Scale (NPRS)
- Pain present most days of the week
You likely can't join if
- Acute pain in any body region
- Neurological disorders or myopathies
- Chronic pain of non-musculoskeletal origin
- Active cancer diagnosis
- History of trauma, fractures, or surgery in the past year
- Pregnancy
See the full eligibility criteria
- Adults aged 18 to 65 years
- Diagnosis of chronic musculoskeletal pain in the lumbar spine, cervical spine, shoulder, or knee
- Pain duration longer than 3 months
- Pain intensity ≥3/10 on the Numeric Pain Rating Scale (NPRS)
- Pain present most days of the week
- Able to understand and speak the Greek language
- Acute pain in any body region
- Neurological disorders or myopathies
- Chronic pain of non-musculoskeletal origin
- Active cancer diagnosis
- History of trauma, fractures, or surgery in the past year
- Pregnancy
- Diagnosis of fibromyalgia
- Cognitive impairments affecting communication or completion of questionnaires
- Current use of corticosteroid medication
- Participation in other treatment programs or alternative therapies during the study period
- Concurrent enrollment in another clinical trial
The study team makes the final eligibility decision.
Where it's taking place
- Lamia, Central Greece, Greece
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lamia, Central Greece, Greece. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.